Centene (CNC) News Today

Centene Corporation (NYSE: CNC) shares are trading lower amid a wave of legal actions and analyst revisions, despite a few potential catalysts for recovery.

• Positive Sentiment: Oppenheimer initiated coverage with an Outperform rating, citing turnaround potential after guidance setbacks. Oppenheimer Initiates Outperform on Centene
• Neutral Sentiment: Meridian Health Plan and the Centene Foundation announced a $1 million grant to Michigan food banks, enhancing the company’s community engagement profile. Meridian and the Centene Foundation Announce $1 Million Grant
• Neutral Sentiment: Benzinga reports that large options traders are taking positions in CNC, indicating heightened speculative interest. This Is What Whales Are Betting On Centene
• Negative Sentiment: Hagens Berman filed a securities suit after Centene’s stock plunged over 10% in pre-market trading following disappointing Q2 results and allegations of inflated guidance. CNC Faces Shareholder Ire Amidst Plummeting Stock
• Negative Sentiment: Cantor Fitzgerald slashed its FY2025 EPS forecast from $4.27 to $1.71, reflecting weaker profitability expectations and maintaining a neutral rating with a $38 target. Centene FY2025 EPS Estimate Reduced by Cantor Fitzgerald
• Negative Sentiment: Multiple law firms—including Rosen, Pomerantz, Levi & Korsinsky, Bleichmar Fonti & Auld, Glancy Prongay & Murray, The Gross Law Firm, Schall Law Firm and DJS Law Group—have filed or announced securities fraud class actions covering December 2024 to June 2025. CNC Investors Have Opportunity to Lead Securities Fraud Lawsuit
• Negative Sentiment: Shares hit a new one-year low after an analyst downgrade, underscoring waning confidence among Wall Street analysts. Centene Sets New 1-Year Low on Analyst Downgrade
• Negative Sentiment: Jim Cramer labeled CNC “one of the most horrible stocks in the group,” reflecting skepticism from high-profile market commentators. Jim Cramer on Centene